888216-48-6

Basic information

• Product Name: BENZOIC ACID, 2,4-DIMETHOXY-5-(1-METHYLETHYL)-
• Synonyms: BENZOIC ACID, 2,4-DIMETHOXY-5-(1-METHYLETHYL)-;5-Isopropyl-2,4-dimethoxybenzoic acid
• CAS NO: 888216-48-6
• Molecular Formula: C₁₂H₁₆O₄
• Molecular Weight: 224.254
• Mol File: 888216-48-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: BENZOIC ACID, 2,4-DIMETHOXY-5-(1-METHYLETHYL)-(CAS DataBase Reference)
• NIST Chemistry Reference: BENZOIC ACID, 2,4-DIMETHOXY-5-(1-METHYLETHYL)-(888216-48-6)
• EPA Substance Registry System: BENZOIC ACID, 2,4-DIMETHOXY-5-(1-METHYLETHYL)-(888216-48-6)

Safety Data

• Hazardous Substances Data: 888216-48-6(Hazardous Substances Data)

Upstream product

• 2150-47-2 methyl 2,4-dihydroxybenzoate 
• 943519-37-7 2,4-dihydroxy-5-isopropylbenzoic acid methyl ester 
• 912545-08-5 2,4-bis-benzyloxy-5-isopropenyl-benzoic acid methyl ester 
• 913000-28-9 methyl 5-isopropyl-2,4-dimethoxybenzoate 
• 829-20-9 2',4'-dimethoxyacetophenone 
• 7051-14-1 1-isopropyl-2,4-dimethyloxybenzene 
• 96826-27-6 2-(2,4-dimethoxyphenyl)propan-2-ol 
• 1071151-44-4 5-isopropyl-2,4-dimethoxybenzaldehyde 

Downstream Products

• 913000-29-0 (5-bromo-1,3-dihydro-isoindol-2-yl)-(5-isopropyl-2,4-dimethoxyphenyl)-methanone 

Relevant articles and documents

Effective synthesis of novel dihydrobenzisoxazoles bearing the 2-aminothiazole moiety and evaluation of the antiproliferative activity of their acylated derivatives

An effective method for the synthesis of 8-aryl-4,5-dihydrothiazolo[4′,5′:3,4]benzo[1,2-c]isoxazol-2-amines was developed. This method includes the α-keto bromination of 3-aryl-6,7-dihydrobenzo[c]isoxazol-4(5H)-ones followed by the condensation of the obt

(2,4-dihydroxy-5-isopropylphenyl)(4,6-dihydro-5H-thieno[2,3-c]pyrrol-5-yl)ketone derivative, preparation and uses thereof

The present invention discloses a (2,4-dihydroxy-5-isopropylphenyl)(4,6-dihydro-5H-thieno[2,3-c]pyrrol-5-yl)ketone derivative, preparation and uses thereof, and particularly relates to a (2,4-dihydroxy-5-isopropylphenyl)(4,6-dihydro-5H-thieno[2,3-c]pyrrol

PHARMACEUTICAL COMPOUNDS

The invention provides a compound of the formula (1 ): or a salt, solvate, N-oxide or tautomer thereof; wherein either R1 is R1a and R2 is R2a; or R1 is R1b and R2 is R2b; provided that in each case at least one of R1 and R2 is other than hydrogen; R1a and R2a are the same or different and each is selected from hydrogen, C1-4 alkyl, C2-4 alkenyl and C2-4 alkynyl wherein the C1-4 alkyl is optionally substituted by C1-2 alkoxy; R1b and R2b are the same or different and are selected from hydrogen, C(O)NR4R5, C(O)R6 and C(O)OR6 where R6 is C1-4 alkyl, R4 and R5 are both C1-4 alkyl, or NR4R5 forms a 4 to 7 membered saturated heterocyclic ring optionally containing a second heteroatom ring member selected from O, N or S and oxidised forms of N and S, the heterocyclic ring being optionally substituted by one or two C1-4 alkyl groups and/or one or two oxo groups; and R3 is a group (D): wherein the asterisk denotes the point of attachment to the isoindoline ring; but excluding acetic acid 5-acetoxy-4-isopropyl-2-[5-(4-methyl-piperazin-1 -ylmethyl)-1,3- dihydro-isoindole-2-carbonyl]-phenyl ester.